Salta al contenuto principale

Per favore
selezionare il paese

Attenzione, le pagine di questa sezione sono disponibili solo in lingua inglese.

Selezionando la visualizzazione internazionale, l'utente dichiara di risiedere al di fuori degli Stati Uniti e di voler visualizzare le informazioni sui prodotti internazionali di DiaSorin Molecular. Questo materiale è destinato esclusivamente ai visitatori internazionali (non statunitensi) del sito.

Ai sensi delle Linee Guida del Ministero della Salute del 28/03/2013 in materia di pubblicità sanitaria relativa a dispositivi medici, dispositivi medico-diagnostici in vitro e presidi medico-chirurgici, si informa che le informazioni contenute in questo sito e alle quali si accede sono destinate esclusivamente agli operatori professionali.

Direct links

LIAISON® BRAHMS MR-proADMTM

A powerful solution for Emergency Department (ED) decision-making.

Accurate prioritization of critically ill patients with suspected infection for timely and informed decision-making when every second counts.

Tell us who you are

Indications for use

Diagnosis

Evaluate risk assessment and prognosis in suspected acute viral, bacterial, parasitic or fungal infections

Target patient

Adults

Use area

Emergency department, urgent care and hospitalized patients

Background

Empower your lab with a new solution to support ED and ICU physicians in improving patient care

The role of the clinical laboratory in supporting clinical decision-making is crucial. Empower your laboratory with the new MR-proADMTM biomarker, to assess disease severity and potential disease progression in patients presenting to the emergency department (ED) with a suspected acute infection.

LIAISON® BRAHMS MR-proADMTM  is a high-quality quantitative CLIA assay that measures the concentration of the blood biomarker Mid-regional pro-adrenomedullin (MR-proADMTM) to assess disease severity and prognosis in patients with a suspected infection.  

Incorporation into the laboratory routine may therefore aid rapid clinical decision-making to either initiate, escalate or intensify early treatment strategies, or identify patients suitable for safe out-patient treatment.   

How it works

LIAISON® BRAHMS MR-proADMTM automatically quantifies the circulating MR-proADMTM in a plasma sample, to evaluate the severity of endothelial dysfunction and the risk of organ failure and/or sepsis development in several clinical conditions: sepsis and septic shock, urinary tract infections (UTI); lower respiratory tract infections (LRTI) and kidney diseases.  

Accurately detects patients at risk in the ED and ICU

01

No need for specialized staff

The fully automated LIAISON® BRAHMS MR-proADMTM test is part of Diasorin’s comprehensive portfolio of immunoassays, allowing any laboratory to optimize its diagnostic pathway while meeting critical emergency department timelines.

02

35 minutes to results

Fast results give clinicians swift answers in emergency situations.

03

High-quality, ready-to-use CLIA assay

Standardized and unbiased results with automatic processing ensures optimal harmonization between urgent, specialty and routine tests

Soluzione diagnostica per la prioritizzazione dei pazienti con sospette infezioni

Why use LIAISON® BRAHMS MR-proADMTM

Quick, objective diagnostics to improve your precision and responsiveness.

Pioneering, easy-to-use diagnostic solution

The easy, intuitive process ensures perfect harmonization between urgent, specialty and routine tests.

Meet critical emergency department timelines

Optimize your diagnostic pathway and deliver faster time-to-results without the need for additional staff.

Better performance for an innovative biomarker

MR-proADMTM offers an accurate and reliable evaluation of endothelial and microcirculatory damage to rapidly identify the risk of organ damage.

Empower your lab

Dynamic throughput with fully automated processing improves response time without increasing operational costs.

To be used on

Designed for both specialty and routine tests, LIAISON® XL and LIAISON® XS immunoassay analyzers help your laboratory handle multiple patients and tests simultaneously. LIAISON® systems are trustworthy, intuitive and deliver automated continuous operation with minimal user intervention. The result is reduced turnaround time, optimal cost management and unmatched growth potential.

Strumento di Immunodiagnostica per grandi laboratori LIAISON® XL - Diasorin

LIAISON® XL

Designed for large laboratories. Fuse the benefits of high throughput and high sensitivity within a powerful and fully automated system that can seamlessly connect to facilitate Total Laboratory Automation. 

Discover more
Analizzatore per Immunodiagnostica LIAISON® XS - Diasorin

LIAISON® XS

A fully automated, easy-to-use benchtop analyzer. Maximize productivity with optimal cost management, no daily maintenance, straightforward integration, and the same capabilities as Diasorin’s high-throughput analyzers. 

Discover more

More details about our diagnostic solutions

Login to Dialog for additional resources

Login to our repository for instructions for use and user manuals, assay information, protocols and much more.

Dialog

Get in touch

If you need any information about our products, contact our specialists. 

Contact us

Need any help?

Get help with Diasorin products and services.

Ask for support

All the products in this family

Discover the range of specialty tests available

Discover more

Indications for use

Diagnosis

Evaluate risk assessment and prognosis in suspected acute viral, bacterial, parasitic or fungal infections

Target patient

Adults

Use area

Emergency department, urgent care and hospitalized patients

Background

Safely identify severely ill patients to improve ED risk stratification and triage level determination

There is a lack of validated tools (blood biomarkers and clinical scores) to timely assess potential disease progression and hospitalization decisions in patients presenting to the emergency department (ED) with a suspected acute infection.

LIAISON® BRAHMS MR-proADM™ is a high-quality quantitative CLIA assay that measures the concentration of the blood biomarker Mid-regional pro-adrenomedullin (MR-proADM™) to assess disease severity and prognosis in patients with a suspected infection.   

Incorporation into an early sepsis management protocol at ED triage, may therefore aid the rapid decision-making to either initiate, escalate or intensify early treatment strategies, or identify patients suitable for safe out-patient treatment.

How it works

LIAISON® BRAHMS MR-proADM™ automatically quantifies the circulating MR-proADM™ in a plasma sample, to evaluate the severity of endothelial dysfunction and the risk of organ failure and/or sepsis development in several clinical conditions: sepsis and septic shock, urinary tract infections (UTI); lower respiratory tract infections (LRTI) and kidney diseases. 

Accurately detects patients at risk in the ED and ICU

01

35 minutes to results

Aid timely clinical decision making (rule in/rule out hospitalization) using LIAISON® analyzers.

02

Optimized patient disposition at ED

Identify early signs of sepsis and organ failure in patients with an infection – regardless of its etiology: bacterial, viral or fungal.

03

Easy-to-interpret results

Explicit cut-off values indicate whether to hospitalize or safely discharge the patient.

proADM

Why use LIAISON® BRAHMS MR-proADMTM

Streamlines the clinical pathway.

Early diagnosis of sepsis

Early identification of high-risk patients, reduction of adverse events, improved prognosis at ED.

Improved bed management at ED

Better ED patient flow and more time and space for trauma and patients in need of ED resources.

Cost savings

Better overall utilization of hospital resources (e.g., less labor, fewer admissions and additional tests required).

Increased patient satisfaction

Optimized diagnostic pathway improves the quality of healthcare.

To be used on

Designed for both specialty and routine tests, LIAISON® XL and LIAISON® XS immunoassay analyzers help your laboratory handle multiple patients and tests simultaneously. LIAISON® systems are trustworthy, intuitive and deliver automated continuous operation with minimal user intervention. The result is reduced turnaround time, optimal cost management and unmatched growth potential.

Strumento di Immunodiagnostica per grandi laboratori LIAISON® XL - Diasorin

LIAISON® XL

Designed for large laboratories. Fuse the benefits of high throughput and high sensitivity within a powerful and fully automated system that can seamlessly connect to facilitate Total Laboratory Automation. 

Discover more
Analizzatore per Immunodiagnostica LIAISON® XS - Diasorin

LIAISON® XS

A fully automated, easy-to-use benchtop analyzer. Maximize productivity with optimal cost management, no daily maintenance, straightforward integration, and the same capabilities as Diasorin’s high-throughput analyzers. 

Discover more

More details about our diagnostic solutions

Login to Dialog for additional resources

Login to our repository for instructions for use and user manuals, assay information, protocols and much more.

Dialog

Get in touch

If you need any information about our products, contact our specialists. 

Contact us

Need any help?

Get help with Diasorin products and services.

Ask for support

All the products in this family

Discover the range of specialty tests available

Discover more